Candel Therapeutics CADL
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 5.65 | 55.96 | -0.55 | -15,663 | -29 | |
| 2025Q3 | 5.10 | 118.90 | -0.22 | -13,207 | -11 | |
| 2025Q2 | 5.06 | 245.11 | -0.08 | -11,177 | -5 | |
| 2025Q1 | 5.65 | -105.79 | 0.13 | -8,130 | 7 | |
| 2024Q4 | 8.68 | 59.50 | -0.39 | -8,141 | -14 | |
| 2024Q3 | 6.93 | 86.20 | -0.32 | -8,757 | -11 | |
| 2024Q2 | 6.20 | 39.55 | -0.75 | -8,571 | -22 | |
| 2024Q1 | 1.58 | 104.32 | -0.28 | -7,902 | -8 | |
| 2023Q4 | 1.47 | 99.00 | -0.38 | -10,318 | -11 | |
| 2023Q3 | 0.92 | 114.10 | -0.29 | -8,861 | -8 | |
| 2023Q2 | 1.26 | 106.79 | -0.34 | -9,579 | -10 | |
| 2023Q1 | 1.35 | 108.27 | -0.30 | -9,633 | -9 | |
| 2022Q4 | 1.79 | 141.55 | -0.17 | -8,101 | -5 | |
| 2022Q3 | 3.14 | 103.48 | -0.31 | -8,882 | -9 | |
| 2022Q2 | 3.24 | 231.32 | -0.14 | -8,753 | -4 | |
| 2022Q1 | 5.09 | 1285.55 | -0.03 | -8,986 | -1 | |
| 2021Q4 | 7.82 | -481.64 | 0.51 | -7,740 | 2 | |
| 2021Q3 | 10.84 | 49.72 | -0.57 | -8,029 | -16 | |
| 2021Q2 | 31.06 | -1.47 | -5,300 | -17 | ||
| 2021Q1 | 104.28 | -0.38 | -4,657 | -4 |